Akihiko Shimizu1, Takeshi Mitsuhashi2, Takashi Nitta3, Hideo Mitamura4, Takashi Kurita5, Haruhiko Abe6, Yuji Nakazato7, Naokata Sumitomo8, Kazushige Kadota9, Kazuo Kimura10, Ken Okumura11. 1. Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi 755-8505, Japan. 2. Jichi Medical University Saitama Medical Center, Saitama, Japan. 3. Nippon Medical School, Tokyo, Japan. 4. Tachikawa Hospital, Tokyo, Japan. 5. Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan. 6. University of Occupational and Environmental Health, Fukuoka, Japan. 7. Juntendo University Urayasu Hospital, Chiba, Japan. 8. Nihon University School of Medicine, Tokyo, Japan. 9. Kurashiki Central Hospital, Okayama, Japan. 10. Yokohama City University Medical Center, Kanagawa, Japan. 11. Hirosaki University Graduate School of Medicine, Aomori, Japan.
Abstract
BACKGROUND: There is little information regarding appropriate therapies for coronary artery disease (CAD) patients with implantable devices - such as implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRT-Ds) and cardiac resynchronization therapy pacemaker (CRT-P) devices - in Japan. To address this lack of information, we have launched the Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study. METHODS: This study has been designed as a prospective, multicenter, non-randomized and observational investigation. All patients will be followed up every six months over a two-year period. The primary endpoint will be the administration of appropriate device therapy. Secondary endpoints include administration of inappropriate therapy, death, hospitalization, or cardiovascular events. CONCLUSION: In this report, we discuss the current clinical situation of appropriate therapy, and how it is influenced by catheter ablation and revascularization therapy in patients with CAD.
BACKGROUND: There is little information regarding appropriate therapies for coronary artery disease (CAD) patients with implantable devices - such as implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRT-Ds) and cardiac resynchronization therapy pacemaker (CRT-P) devices - in Japan. To address this lack of information, we have launched the Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study. METHODS: This study has been designed as a prospective, multicenter, non-randomized and observational investigation. All patients will be followed up every six months over a two-year period. The primary endpoint will be the administration of appropriate device therapy. Secondary endpoints include administration of inappropriate therapy, death, hospitalization, or cardiovascular events. CONCLUSION: In this report, we discuss the current clinical situation of appropriate therapy, and how it is influenced by catheter ablation and revascularization therapy in patients with CAD.
Entities:
Keywords:
Cardiac implantable devices; Coronary artery disease; Implantable cardioverter-defibrillator; Japan
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245
Authors: Jay Chen; George Johnson; Anne S Hellkamp; Jill Anderson; Daniel B Mark; Kerry L Lee; Gust H Bardy; Jeanne E Poole Journal: J Am Coll Cardiol Date: 2013-03-26 Impact factor: 24.094
Authors: Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin Journal: Circulation Date: 2004-12-06 Impact factor: 29.690
Authors: Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow Journal: J Am Coll Cardiol Date: 2013-03-07 Impact factor: 24.094